In our 2012-2013 Seed Grant Program Alexander Tzatsos, MD, PhD, was a recipient of a $50,000 award to study the epigenetics of pancreatic cancer. We are pleased to announce he […]
Metformin’s Anti-Cancer Properties Clarified in an Obesity Cell Model of Pancreatic Cancer
SiDMAP and University of Arizona researchers gain a clearer understanding of the mechanistic properties of the drug metformin. The study may explain the mechanism of how elevated circulating cholesterol, which […]
Hirshberg Foundation for Pancreatic Cancer Research Announces the 2012-2013 Seed Grant Award Recipients
Final Media Contact: Donald Wilson (310) 899-2900 dwilson@mcraigassociates.com THE HIRSHBERG FOUNDATION FOR PANCREATIC CANCER RESEARCH ANNOUNCES THE 2012-2013 SEED GRANT AWARD RECIPIENTS LOS ANGELES, Calif., – (November 1, 2012) – […]
Hirshberg Researcher Receives New Grant for $10 Million!
We are pleased to announce that Guido Eibl, M.D., Principal Investigator and Scientific Director of the Ronald S. Hirshberg Translational Pancreatic Cancer Research Laboratory at the UCLA School of Medicine, […]
UCLA study pinpoints types of bacteria in saliva associated with pancreatic cancer
By Rachel Champeau October 13, 2011 UCLA RESEARCH ALERT FINDINGS: A UCLA study has found variations in the types of bacteria found in the saliva of patients with pancreatic […]
Hirshberg Foundation funds UCLA study of fructose in pancreatic cancer
Read in the Washington Post: By Reuters Tuesday, August 3, 2010 Fructose helps pancreatic cancer cells to multiply, UCLA study finds WASHINGTON — Pancreatic tumor cells use fructose to divide […]